| Bioactivity | PARG-IN-4 (Formula (A)) is an orally active and cell-permeable PARG inhibitor. PARG-IN-4 effectively inhibits tumor growth in mouse models. PARG-IN-4 can be used in cancer research[1]. |
| Name | PARG-IN-4 |
| CAS | 2988890-20-4 |
| Formula | C20H25F2N7O2S2 |
| Molar Mass | 497.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Paul A Barsanti, et al. Piperazine substituted indazole compounds as inhibitors of parg. Patent WO2023183850A1. |
PARG-IN-4
CAS: 2988890-20-4 F: C20H25F2N7O2S2 W: 497.59
PARG-IN-4 (Formula (A)) is an orally active and cell-permeable PARG inhibitor. PARG-IN-4 effectively inhibits tumor grow
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.